Oct 1 |
IGM Biosciences' New Found Focus: Pivots From Cancer To Autoimmune Diseases, Names New CEO
|
Oct 1 |
IGM Biosciences downgraded to Hold, stock falls
|
Oct 1 |
These Stocks Are Moving the Most Today: Boeing, Super Micro, HP Inc., CVS, Ford, NIO, IGM Biosciences, and More
|
Oct 1 |
Top 1% Biotech, IGM Biosciences, Plummets On Scrapped Drug, C-Suite Makeover
|
Oct 1 |
IGM Biosciences Stock Drops Sharply on ‘Pipeline Transformation’ to Autoimmune Diseases
|
Oct 1 |
IGM lays off staff in autoimmune pivot; Metsera ramps up obesity drug supply
|
Sep 30 |
IGM Biosciences to minimize spending on oncology candidates, appoints new CEO
|
Sep 30 |
IGM Biosciences Announces Strategic Pivot to Focus Exclusively on Autoimmunity
|
Sep 27 |
While shareholders of IGM Biosciences (NASDAQ:IGMS) are in the black over 1 year, those who bought a week ago aren't so fortunate
|
Sep 18 |
IGM Biosciences: Waiting For Godot
|